Company / R&D per Share
Arcadia Biosciences, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.04
FY2025
5-year range
$0.04 / $7.01
FY2021-FY2025
Trend
-22.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has declined for 3 consecutive years, from $7.01 in FY2022 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of -45.7%.
Declined from $2.45 to $0.04 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -82.3%
- 5-Year CAGR
- -45.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 22.0% year-over-year.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -22.0% |
| FY2024 | $0.05 | -98.0% |
| FY2023 | $2.45 | -65.1% |
| FY2022 | $7.01 | +1084.9% |
| FY2021 | $0.59 | -27.9% |
| FY2020 | $0.82 | -35.4% |
| FY2019 | $1.27 | -63.4% |
| FY2018 | $3.47 | -10.9% |
| FY2017 | $3.89 | +1819.2% |
| FY2016 | $0.20 | -95.8% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026